Cargando…
Hepatitis B Virus X Protein-Induced Serine Protease Inhibitor Kazal Type 1 Is Associated with the Progression of HBV-Related Diseases
OBJECTIVE: Hepatitis B virus (HBV) causes inflammation of the liver and is the leading cause of both liver cirrhosis (LC) and hepatocellular carcinoma (HCC). Serine protease inhibitor Kazal type 1 (SPINK1) is an acute-phase response protein that is overexpressed in liver cancer tissue. This study in...
Autores principales: | Zhu, Chengliang, Han, Huan, Li, Jie, Xu, Limin, Liu, Fang, Wu, Kailang, Liu, Xinghui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6556357/ https://www.ncbi.nlm.nih.gov/pubmed/31240230 http://dx.doi.org/10.1155/2019/9321494 |
Ejemplares similares
-
Generation and Analysis of Serine Protease Inhibitor Kazal Type 3-Cre Driver
Mice
por: Sakata, Kazuya, et al.
Publicado: (2014) -
Regulation of serine protease inhibitor Kazal type-5 (SPINK5) gene expression in the keratinocytes
por: Le, Ngoc Anh, et al.
Publicado: (2014) -
Kazal-type serine proteinase inhibitors in the midgut
of Phlebotomus papatasi
por: Sigle, Leah Theresa, et al.
Publicado: (2013) -
Genetic polymorphisms in serine protease inhibitor Kazal-type 5 and risk of atopic dermatitis: A meta-analysis
por: Li, Yunling, et al.
Publicado: (2020) -
Molecular Cloning and Functional Studies of Two Kazal-Type Serine Protease Inhibitors Specifically Expressed by Nasonia vitripennis Venom Apparatus
por: Qian, Cen, et al.
Publicado: (2015)